|
|
Office Locations:
|
360 Post Street, Suite 601
San Francisco, CA 94108
Phone: 415-765-6980
Fax: 415-765-6983
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded 2001, Telegraph Hill Partners (THP) is a venture capital and growth equity firm dedicated to building life science and healthcare technology businesses. The firm targets commercial companies in growth areas within the healthcare sector, including life science technologies, medical devices, chemistry and reagent suppliers, healthcare services and information management. THP typically invests $2-8 million in portfolio companies. The firm targets companies that are beyond development stage and have entered the commercialization phase with quality products and a focus on building revenues and profits. Telegraph Hill announced (July 2022) that it has closed on THP V, a new $525 million investment fund.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
